Deep Bio ’s Prostate Cancer Diagnostic Software Demonstrates High...
Two posters featuring analyses by Deep Bio’s AI algorithm for prostate cancer diagnosis, DeepDx®, were highlighted at AUA 2021(PRWeb October 18, 2021)Read the full story at https://www.prweb.com/releases/deep_bios_prostate_cancer_diagnostic_software_demonstrates_high_concordance_with_uropathologists_at_aua_2021/prweb18266996.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 18, 2021 Category: Pharmaceuticals Source Type: news

Gut Bacteria May Fuel Prostate Cancer Treatment Resistance Gut Bacteria May Fuel Prostate Cancer Treatment Resistance
During prostate cancer treatment, some gut bacteria start making hormones that may support cancer growth and treatment resistance.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 15, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

PET/MRI bests MRI alone for detecting recurrent prostate cancer
PET/MRI is superior to MRI alone for detecting disease in patients with recurren...Read more on AuntMinnie.comRelated Reading: Prostate cancer imaging tracers evaluated head-to-head Radiology contributes to high spending costs in cancer care Blue Earth highlights new Axumin research AI can detect metastatic bone lesions on scintigraphy PET tracer assesses response to new prostate cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 15, 2021 Category: Radiology Source Type: news

Gut Bacteria May Fuel Prostate Cancer Treatment Resistance
During prostate cancer treatment, some gut bacteria start making hormones that may support cancer growth and treatment resistance. (Source: WebMD Health)
Source: WebMD Health - October 15, 2021 Category: Consumer Health News Source Type: news

Ghana: Almonds Can Lower Cholesterol Levels and Avert Prostate Cancer
[Ghanaian Times] The Bible makes numerous references to almonds, describing them as an object of value and a symbol of hope, for example, in Genesis 43:11. Today, Ayurveda practitioners believed that almonds were capable of increasing brain capacity, intellectual ability and longevity. Almonds are in two ranges: sweet and bitter. According to Levy(2019), oils from sweet almonds are extracted to form almond oil, a beneficial and hydrating oil with many healing body and household uses. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 15, 2021 Category: African Health Source Type: news

PET/MRI bests MRI alone detecting recurrent prostate cancer
PET/MRI is superior to MRI alone for detecting disease in patients with recurren...Read more on AuntMinnie.comRelated Reading: Prostate cancer imaging tracers evaluated head-to-head Radiology contributes to high spending costs in cancer care Blue Earth highlights new Axumin research AI can detect metastatic bone lesions on scintigraphy PET tracer assesses response to new prostate cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 15, 2021 Category: Radiology Source Type: news

Researchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with cryoablation for patients with unresectable malignant mesothelioma. The phase I trial opened in September and will be available at seven Memorial Sloan Kettering locations in the New York City/New Jersey area. Cryoablation, which is also known as cryotherapy or cryosurgery, is a treatment that freezes localized tumors with argon gas or liquid nitrogen. It has been used effectively with liver, kidney and prostate cancers, but its use with mesothelioma has been limited because of ...
Source: Asbestos and Mesothelioma News - October 14, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Clinical Advances in Prostate Cancer From ESMO 2021 Clinical Advances in Prostate Cancer From ESMO 2021
Prof Johann de Bono discusses prostate cancer data from ESMO 2021, including abiraterone plus prednisolone in nonmetastatic disease, two key trials in the metastatic setting, and 177Lu-PSMA-617.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 13, 2021 Category: Consumer Health News Tags: None ReCAP Source Type: news

Penn State team secures funding to develop wearable brain scanner
Researchers from Pennsylvania State University have been awarded a two-year...Read more on AuntMinnie.comRelated Reading: Photoacoustic US shows promise for visualizing lymphatic vessels Ultrasound + photoacoustic imaging spot prostate cancer New imaging method could boost ovarian cancer detection Group reveals work on hybrid acoustic-optical imaging Photoacoustic US offers option to thyroid biopsy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2021 Category: Radiology Source Type: news

Sofie submits IND application for pancreatic PET agent
Molecular imaging developer Sofie Biosciences has submitted an investigationa...Read more on AuntMinnie.comRelated Reading: iTheranostics, Novartis ink FAP-targeted drug development agreement Sofie, Lantheus ink deal for prostate cancer imaging agent Jubilant inks deal to invest $25M in Sofie Sofie signs deal with ABX for cGMP compliance Sofie signs exclusive license for new FAPI radiotracers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 12, 2021 Category: Radiology Source Type: news

Supplements warning: The vitamin that 'significantly' increases risk of cancer in men
MOST people do not need to take vitamin supplements because they can get all the vitamins and minerals they need by eating a healthy, balanced diet. However, the supplement market is booming. According to one study, supplementing with a popular vitamin hiked the risk of prostate cancer in men. (Source: Daily Express - Health)
Source: Daily Express - Health - October 12, 2021 Category: Consumer Health News Source Type: news

The relationship between the severity of insomnia and falls in the elderly - İleri, Borazan FY, Cavusoglu C, Göker B.
BACKGROUND: Insomnia is associated with depression, cognitive impairment, hypertension, myocardial infarction, stroke, metabolic syndrome and prostate cancer in the elderly. The aim of this study is to investigate the relationship between severity of insom... (Source: SafetyLit)
Source: SafetyLit - October 11, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Prostate cancer imaging tracers evaluated head-to-head
Korean researchers have developed a new PET imaging radiotracer that appear...Read more on AuntMinnie.comRelated Reading: Telix applauds NCCN radiotracer update PET tracer assesses response to new prostate cancer treatment PET/MRI better than MRI alone for detecting prostate cancer Ga-68 PSMA-11 improves outcomes in prostate cancer patients Lantheus gets FDA nod for Pylarify PET agent for prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 8, 2021 Category: Radiology Source Type: news

The Return of Metastatic Prostate Cancer The Return of Metastatic Prostate Cancer
Henry Rosevear, MD, explores why we're seeing a rise in the incidence of metastatic prostate cancerMedscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Accuray inks collaboration with C-RAD
Radiation therapy firm Accuray has signed a collaboration agreement with C-RA...Read more on AuntMinnie.comRelated Reading: Accuray promotes prostate cancer research at ESTRO 2021 Accuray lands Radixact install in India Accuray reports revenue increase for Q4 Accuray receives CE Mark for ClearRT imaging Accuray appoints chief medical, technology officer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 4, 2021 Category: Radiology Source Type: news

Zimbabwe: Increase Health Seeking Behavior to Fight Prostate Cancer, Men Told
[263Chat] Deputy Minister of Health and Child Care Dr John Mangwiro has urged men to increase their health seeking behavior. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 1, 2021 Category: African Health Source Type: news

Abiraterone acetate plus ADT most cost effective option for metastatic prostate cancer in the USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news

New Tests for Colon, Prostate Cancer Show Promise
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 29, 2021 Category: Cancer & Oncology Tags: Oncology, Research, Preventive Medicine, News, Source Type: news

New Tests for Colon, Prostate Cancer Show Promise
Title: New Tests for Colon, Prostate Cancer Show PromiseCategory: Health NewsCreated: 9/29/2021 12:00:00 AMLast Editorial Review: 9/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - September 29, 2021 Category: Cancer & Oncology Source Type: news

Ghana: Men Above 40 Yrs Advised to Screen for Prostrate Cancer
[Ghanaian Times] Vice president of the Cancer Support Network of Ghana, Mr Eric Odei Brobbey, has advised men above 40 years of age to take prostate cancer screening seriously as the disease usually showed symptoms after it had advanced. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 28, 2021 Category: African Health Source Type: news

NCCN Guidelines Embrace PSMA-PET Imagining for Prostate Cancer NCCN Guidelines Embrace PSMA-PET Imagining for Prostate Cancer
Imaging with PSMA-PET excels at detecting small metastatic lesions in men with prostate cancer, but some specialists worry that it could lead to upstaging and overtreatment of men with lower-risk disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCCN Guidelines Embrace PSMA-PET Imaging for Prostate Cancer NCCN Guidelines Embrace PSMA-PET Imaging for Prostate Cancer
Imaging with PSMA-PET excels at detecting small metastatic lesions in men with prostate cancer, but some specialists worry that it could lead to upstaging and overtreatment of men with lower-risk disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Abiraterone Acetate + Prednisone Cuts Metastasis in Prostate Cancer
And standard of care plus abiraterone improves survival in men with metastatic castration - sensitive prostate cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 27, 2021 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Conference News, Source Type: news

PSMA PET Imaging Pinpoints Most Pelvic Nodal Metastases in High-Risk Prostate Cancer PSMA PET Imaging Pinpoints Most Pelvic Nodal Metastases in High-Risk Prostate Cancer
Diagnostic imaging with 68Ga-PSMA-11 PET detects about 80% of pelvic nodal metastases at initial staging of intermediate to high-risk prostate cancer, but a negative scan does not rule out the need for dissection, researchers say.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 23, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer
Latest results from the STAMPEDE trial show that adding abiraterone to androgen deprivation therapy improved both metastasis-free and overall survival.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Researchers identify new subtypes of metastatic prostate cancer
Researchers have identified two new subtypes of metastatic prostate cancer that respond differently to treatment, they reported in a study published Thursday by JAMA Oncology. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 23, 2021 Category: Consumer Health News Source Type: news

First AI Pathology Program Approved: Helps Detect Prostate Cancer First AI Pathology Program Approved: Helps Detect Prostate Cancer
Paige Prostate was approved as an adjunct to pathologist review, not a replacement. It increases detection of cancer by an average of 7.3%.FDA Approvals (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 22, 2021 Category: Surgery Tags: Hematology-Oncology News Alert Source Type: news

Paige receives FDA De Novo clearance for AI to detect prostate cancer
Paige Prostate analyzes digitized biopsy slides and identifies areas that could be cancerous for the pathologist to review further. (Source: mobihealthnews)
Source: mobihealthnews - September 22, 2021 Category: Information Technology Source Type: news

SNMMI updates appropriate use criteria for PSMA PET
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released ne...Read more on AuntMinnie.comRelated Reading: Telix applauds NCCN radiotracer update Pylarify added to NCCN prostate cancer guidelines CMS revokes PET infection, inflammation imaging barrier SNMMI supports new legislation to fix PET payment policy Humana expands nuclear medicine coverage (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 21, 2021 Category: Radiology Source Type: news

FDA authorizes software that can help identify prostate cancer
Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue removed from the body). (Source: World Pharma News)
Source: World Pharma News - September 21, 2021 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Mayo Clinic Minute: Importance of exercise for men with prostate cancer
Prostate cancer is the second most common cancer in men worldwide. It's important that men are screened for the disease to catch it early, and a recent study shows that exercise and physical activity as an additional therapy may help improve patient outcomes. Watch: The Mayo Clinic Minute https://youtu.be/iPkYBSrb5wY Journalists: Broadcast-quality video (1:02) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic News Network." Read the script. Exercise is good… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 21, 2021 Category: Databases & Libraries Source Type: news

Study: Social media awareness of genetic prostate cancer link lower than with breast cancer
Researchers zeroed in on the role of social media and spreading awareness around prostate cancer and the BRCA  gene.  (Source: mobihealthnews)
Source: mobihealthnews - September 20, 2021 Category: Information Technology Source Type: news

Men Give Thumbs Up to Video on Genetic Testing in Prostate Cancer Men Give Thumbs Up to Video on Genetic Testing in Prostate Cancer
A video about the risks and benefits of germline testing in prostate cancer could help cancer practices ease problems caused by a shortage of trained genetic counselors.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Androgen Deprivation Alone No Longer Acceptable for mCSPC Androgen Deprivation Alone No Longer Acceptable for mCSPC
Androgen deprivation alone is no longer an acceptable option for the treatment of men with metastatic castration-sensitive prostate cancer (mCSPC), experts contend.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 20, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

German Feasibility Study Shows Cerenkov Luminescence Imaging May Provide New Technique for Identifying Positive Margins during Prostatectomies
Prostate cancer currently has the highest positive surgical margin rate of any cancer in men, with 21% of patients left with cancer cells at the resection site Cancer surgeons may soon have a new technology to help them completely remove cancerous tissue during prostate cancer surgery. Called Cerenkov luminescence imaging (CLI), this new diagnostic technology […] The post German Feasibility Study Shows Cerenkov Luminescence Imaging May Provide New Technique for Identifying Positive Margins during Prostatectomies appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - September 20, 2021 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory News Laboratory Pathology Laboratory Testing Managed Care Contracts & Payer Reimbursement anatomic pathology Boris A. Hadaschik PhD Cerenkov luminescence imagin Source Type: news

Prostate cancer drugs that halve risk of dying: New hope for patients thanks to new treatment
Around 10,000 men a year in the UK have an aggressive form of prostate cancer, which is treated with hormone therapy and radiotherapy. A new drug could halve death rates over six years. (Source: the Mail online | Health)
Source: the Mail online | Health - September 20, 2021 Category: Consumer Health News Source Type: news

Men with prostate cancer could be cured in ONE WEEK
Doctors at the London Royal Marsden hospital are this week set to treat the first patient as part of a trial looking into whether it is safe to give radiotherapy in two large doses instead of lots of smaller doses. (Source: the Mail online | Health)
Source: the Mail online | Health - September 20, 2021 Category: Consumer Health News Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral present...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cancer treatment startup Francis Medical raises $55M
The Maple Grove-based company is using the funds to develop its cancer treatment through FDA 510(k) approval, which will include a clinic study for the management of prostate cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 15, 2021 Category: Pharmaceuticals Authors: Carter Jones Source Type: news

Cancer treatment startup Francis Medical raises $55M
The Maple Grove-based company is using the funds to develop its cancer treatment through FDA 510(k) approval, which will include a clinic study for the management of prostate cancer. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2021 Category: Biotechnology Authors: Carter Jones Source Type: news

Accuray promotes prostate cancer research at ESTRO 2021
Radiation oncology firm Accuray is highlighting research presented at the recen...Read more on AuntMinnie.comRelated Reading: Accuray lands Radixact install in India Accuray reports revenue increase for Q4 Accuray receives CE Mark for ClearRT imaging Accuray appoints chief medical, technology officer Accuray to tap Japanese market for ClearRT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 15, 2021 Category: Radiology Source Type: news

Accuray touts Cyberknife research for prostate cancer
Radiation oncology firm Accuray is highlighting research presented at the recen...Read more on AuntMinnie.comRelated Reading: Accuray lands Radixact install in India Accuray reports revenue increase for Q4 Accuray receives CE Mark for ClearRT imaging Accuray appoints chief medical, technology officer Accuray to tap Japanese market for ClearRT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 14, 2021 Category: Radiology Source Type: news

Pylarify added to NCCN prostate cancer guidelines
Lantheus Medical Imaging's PET radiotracer Pylarify (F-18 piflufolastat) ha...Read more on AuntMinnie.comRelated Reading: Lantheus touts Pylarify PET agent results at AUA meeting Lantheus subsidiary wins FDA clearance for AI software Lantheus touts Pylarify clinical results at SNMMI 2021 GenesisCare among early providers to offer Pylarify Lantheus gets FDA nod for Pylarify PET agent for prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 14, 2021 Category: Radiology Source Type: news

Active Surveillance for Prostate Cancer: Switch After 4 Years Active Surveillance for Prostate Cancer: Switch After 4 Years
Active surveillance instead of initial aggressive treatment has become a standard of care for men with low-risk prostate cancer, so why do they switch?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lantheus, RefleXion to collaborate on prostate cancer treatment
Lantheus Medical Imaging parent Lantheus Holdings and radiation therapy equipmen...Read more on AuntMinnie.comRelated Reading: Lantheus touts Pylarify PET agent results at AUA meeting Lantheus subsidiary wins FDA clearance for AI software Lantheus posts revenue gain, larger net loss in Q2 RefleXion to install X1 at cancer center in Texas RefleXion to install X1 system at UPMC RefleXion raises another $40M, mulls Asia strategy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 13, 2021 Category: Radiology Source Type: news

Prostate Cancer Risk Up for World Trade Center Rescue Workers
Risk most elevated for those to arrive earliest at the site, with a shorter latency period than the general population (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 13, 2021 Category: Cancer & Oncology Tags: Internal Medicine, Oncology, Pathology, Urology, Journal, Source Type: news

AI can detect metastatic bone lesions on scintigraphy
An artificial intelligence (AI) algorithm can identify and characterize suspiciou...Read more on AuntMinnie.comRelated Reading: PET recommended over bone scintigraphy in pediatric sarcoma AI aids detection of metastasis on bone scintigraphy Automated bone scan software proves worth with radium-223 NaF-PET/CT does well in detecting prostate metastases Bone scan software predicts prostate cancer survival (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 13, 2021 Category: Radiology Source Type: news

Mayo Clinic Q & amp;A podcast: What happens after a prostate cancer diagnosis?
After skin cancer, prostate cancer is the most common type of cancer in men. One in 8 men will be diagnosed with prostate cancer in his lifetime, according to the National Cancer Institute. While some types of prostate cancer grow slowly, and may need minimal or even no treatment, other types are aggressive and can spread quickly. So if you ’ve been diagnosed with prostate cancer. Now what? "It's very important to know the extent or… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 13, 2021 Category: Databases & Libraries Source Type: news

ERLEADA ® (apalutamide) Oral Presentations Demonstrate Importance of Prostate Specific Antigen (PSA) as Key Efficacy Indicator and Show Strong Patient Adherence Rates
September 11, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data demonstrating robust prostate-specific antigen (PSA) response and strong adherence rates in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with ERLEADA® (apalutamide) in the real-world clinical setting. The strong PSA response was also seen in a separate post-hoc analysis that showed a correlation between rapid and deep PSA response and prolonged survival in both metastatic castration-sensitive prostate cancer (mCSPC) and nmCRPC. The post-hoc analysis also...
Source: Johnson and Johnson - September 12, 2021 Category: Pharmaceuticals Source Type: news

Prostate Cancer Surgeries Plummeted for Black Men in 2020 Prostate Cancer Surgeries Plummeted for Black Men in 2020
Rates of surgery for untreated nonmetastatic prostate cancer differed greatly for Black and White men early in the pandemic, highlighting systemic inequities.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 11, 2021 Category: Cancer & Oncology Tags: Urology News Source Type: news